As of January 30, 2026, Oxycodone 30mg—an immediate-release opioid analgesic—continues to be one of the most tightly controlled pain medications globally due to its high potency, significant abuse liability, and central role in the ongoing opioid epidemic. This formulation provides rapid relief for moderate to severe acute or breakthrough chronic pain (post-surgical, injury-related, cancer pain, […]